Financials
- Market Capitalization 8.16 M
- Employee 8
- Founded 2013
- CEO Murthy Simhambhatla
- Website www.aeonbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00Z17HDW3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4850 | BRTX BioRestorative Therapies, Inc. - Common Stock | 0.34 USD | 0.00% | -10.53% | -5.56% | -78.62% | 8.66 M USD | ||
| 4854 | IMNN Imunon, Inc. - Common Stock | 1.98 USD | +1.02% | -1.49% | -0.50% | -39.08% | 8.32 M USD | ||
| 4863 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.47 USD | +1.56% | +0.24% | +63.51% | -10.92% | 8.05 M USD | ||
| 4873 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 6.08 USD | +1.84% | +8.77% | +20.63% | +289.74% | 7.88 M USD |